Novartis names new CEO as profit jumps 50%

Novartis on Tuesday promotes the head of its pharmaceutical unit to chief executive as the Swiss drugmaker reports a 50% profit rise in the fourth quarter, helped by demand for cancer and blood pressure drugs and pandemic flu vaccines.